Auro Laboratories [ARL] vs Raymond [RAYMOND] Detailed Stock Comparison

Auro Laboratories Ltd.

BSE
Loading...

Raymond Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Auro Laboratories Ltd. wins in 5 metrics, Raymond Ltd. wins in 14 metrics, with 0 ties. Raymond Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Auro Laboratories Ltd. Raymond Ltd. Better
P/E Ratio (TTM) 16.26 55.24 Auro Laboratories Ltd.
Price-to-Book Ratio 1.31 0.89 Raymond Ltd.
Debt-to-Equity Ratio 30.40 29.43 Raymond Ltd.
PEG Ratio 0.06 -0.59 Auro Laboratories Ltd.
EV/EBITDA 12.88 18.42 Auro Laboratories Ltd.
Profit Margin (TTM) 2.06% 248.57% Raymond Ltd.
Operating Margin (TTM) 3.74% 3.91% Raymond Ltd.
EBITDA Margin (TTM) 3.74% 3.91% Raymond Ltd.
Return on Equity 4.52% 183.56% Raymond Ltd.
Return on Assets (TTM) 3.51% 98.90% Raymond Ltd.
Free Cash Flow (TTM) $104.35M $752.80M Raymond Ltd.
1-Year Return -81.34% -14.21% Raymond Ltd.
Price-to-Sales Ratio (TTM) 0.32 1.31 Auro Laboratories Ltd.
Enterprise Value $1.31B $32.61B Raymond Ltd.
EV/Revenue Ratio 0.33 1.48 Auro Laboratories Ltd.
Gross Profit Margin (TTM) 5.78% 42.09% Raymond Ltd.
Revenue per Share (TTM) $174 $331 Raymond Ltd.
Earnings per Share (Diluted) $3.66 $7.86 Raymond Ltd.
Beta (Stock Volatility) 0.24 -0.04 Raymond Ltd.

Auro Laboratories Ltd. vs Raymond Ltd. Stock Performance Analysis

Loading Price Chart...

ARL
RAYMOND

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Auro Laboratories Ltd.-4.98%-7.93%-17.83%-55.23%-88.05%-88.37%
Raymond Ltd.-3.19%-3.62%14.37%36.14%11.74%24.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Auro Laboratories Ltd.-81.34%33.89%57.54%56.31%56.31%56.31%
Raymond Ltd.-14.21%-65.70%36.29%11.45%51.80%21.23%

Performance & Financial Health Analysis: Auro Laboratories Ltd. vs Raymond Ltd.

MetricARLRAYMOND
Market Information
Market Cap i₹1.28B₹28.90B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i56,527652,889
90 Day Avg. Volume i100,337527,460
Last Close₹45.58₹514.95
52 Week Range₹45.58 - ₹470.00₹320.00 - ₹783.90
% from 52W High-90.30%-34.31%
All-Time High₹470.00 (Oct 23, 2025)₹3,496.00 (Jul 08, 2024)
% from All-Time High-90.30%-85.27%
Growth Metrics
Quarterly Revenue Growth0.70%-0.42%
Quarterly Earnings Growth4.54%-0.95%
Financial Health
Profit Margin (TTM) i0.02%2.49%
Operating Margin (TTM) i0.04%0.04%
Return on Equity (TTM) i0.05%1.84%
Debt to Equity (MRQ) i30.4029.43
Cash & Liquidity
Book Value per Share (MRQ)₹45.37₹488.48
Cash per Share (MRQ)₹13.46₹136.87
Operating Cash Flow (TTM) i₹151.50M₹69.27B
Levered Free Cash Flow (TTM) i₹34.72M₹76.31B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Auro Laboratories Ltd. vs Raymond Ltd.

MetricARL (Apr 26, 2026)RAYMOND (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i16.2655.24
Forward P/E iN/A23.34
PEG Ratio i0.06-0.59
Price to Sales (TTM) i0.321.31
Price to Book (MRQ) i1.310.89
Market Capitalization
Market Capitalization i₹1.28B₹28.90B
Enterprise Value i₹1.31B₹32.61B
Enterprise Value Metrics
Enterprise to Revenue i0.331.48
Enterprise to EBITDA i12.8818.42
Risk & Other Metrics
Beta i0.24-0.04
Book Value per Share (MRQ) i₹45.37₹488.48

Financial Statements Comparison: Auro Laboratories Ltd. vs Raymond Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricARL (2025)RAYMOND (2025)
Revenue/Sales i3.14B18.61B
Cost of Goods Sold i3.01B11.87B
COGS % of Revenue i95.9%63.8%
Gross Profit i130.00M6.74B
Gross Margin i4.1%36.2%
Research & Development iN/AN/A
Operating Income (EBIT) i72.07M316.80M
Operating Margin i2.3%1.7%
EBITDA i69.93M2.38B
EBITDA Margin i2.2%12.8%
Pre-Tax Income i46.51M783.40M
Pre-Tax Income % of Revenue i1.5%4.2%
Income Tax i11.79M263.20M
Income Tax % of Revenue i0.4%1.4%
Net Income (Profit) i34.72M76.36B
Profit Margin i1.1%410.4%

Balance Sheet & Liquidity Metrics

MetricARL (2025)RAYMOND (2025)
Cash & Equivalents i236.38M343.70M
Total Current Assets i965.77M52.03B
Total Current Assets % of Revenue i30.8%279.6%
Total Current Liabilities i180.31M30.16B
Total Current Liabilities % of Revenue i5.7%162.1%
Long-Term Debt i39.88M3.45B
Long-Term Debt % of Revenue i1.3%18.5%
Total Shareholders Equity i768.87M41.58B
Retained Earnings iN/A18.59B
Retained Earnings % of Revenue i0.0%99.9%
Property, Plant & Equipment i08.90B

Cash Flow Statement Comparison

MetricARL (2025)RAYMOND (2025)
Operating Cash Flow i151.50M69.27B
Operating Cash Flow % of Revenue i4.8%372.3%
Capital Expenditures i-7.97M-1.42B
Free Cash Flow i104.35M752.80M
FCF Margin i3.3%4.0%
Debt Repayment i-13.81M-1.54B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricARLRAYMOND
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i21.47M66.55M
Float Shares i9.07M31.63M
% Held by Insiders i53.69%51.24%
% Held by Institutions i0.00%8.54%
% Held by Public i46.31%40.22%

Dividend Analysis & Yield Comparison: Auro Laboratories Ltd. vs Raymond Ltd.

MetricARLRAYMOND
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹5.33
3-Year Avg Dividend Yield iN/A0.31%
3-Year Total Dividends iN/A₹16.00
Ex-Dividend DateN/AJun 13, 2024